daunorubicin has been researched along with Autoimmune Thrombocytopenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, K; Gupta, M; Jijina, F; Madkaikar, M; Mohanty, D; Rajpurkar, M | 1 |
| Llorente, L; López-Karpovitch, X; Richaud-Patin, Y; Ruiz-Soto, R | 1 |
| Barnes, C; Blanchette, V; Canning, P; Greenberg, M; Price, V | 1 |
3 other study(ies) available for daunorubicin and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Tuberculosis and immune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Asparaginase; Comorbidity; Daunorubicin; HIV Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; India; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studies; Rifampin; Thrombocytopenia; Tuberculosis; Vincristine | 2002 |
Multidrug resistance-1 (MDR-1) in autoimmune disorders III: increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients.
Topics: Adolescent; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoimmune Diseases; Biomarkers; Case-Control Studies; Daunorubicin; Female; Flow Cytometry; Humans; Lymphocytes; Male; Middle Aged; Prognosis; Purpura, Thrombocytopenic, Idiopathic | 2003 |
Immune thrombocytopenia following successful treatment of cancer in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells; Carmustine; Child, Preschool; Cyclophosphamide; Daunorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasms; Platelet Count; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Vincristine | 2006 |